Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression (Q36095652)

12 August 2017

Genomic and proteomic profiles reveal the association of gelsolin to TP53 status and bladder cancer progression (English)

1 reference

12 August 2017

1 reference

Carlos Cordon-Cardo

1 reference

12 August 2017

Marta Sanchez-Carbayo

1 reference

12 August 2017

Nicholas D Socci

1 reference

12 August 2017

Lee Richstone

1 reference

12 August 2017

Marta Corton

1 reference

12 August 2017

Nille Behrendt

1 reference

12 August 2017

Julia Wulkfuhle

1 reference

12 August 2017

Bernard Bochner

1 reference

12 August 2017

Emmanuel Petricoin

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 November 2007

1 reference

The American Journal of Pathology

12 August 2017

1 reference

12 August 2017

171

1 reference

12 August 2017

1 reference

12 August 2017

1650-1658

1 reference

Mechanisms of Disease: genetic and epigenetic alterations that drive bladder cancer

12 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

p53 mutation heterogeneity in cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

p53: traffic cop at the crossroads of DNA repair and recombination

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

A dynamic podosome-like structure of epithelial cells

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Proteomic profiling of the NCI-60 cancer cell lines using new high-density reverse-phase lysate microarrays

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Development of a prostate cDNA microarray and statistical gene expression analysis package

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Analysis of p53-regulated gene expression patterns using oligonucleotide arrays

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Genetic studies and molecular markers of bladder cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

p53, the cellular gatekeeper for growth and division

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Gelsolin: a candidate for suppressor of human bladder cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Presence and location of TP53 mutation determines pattern of CDKN2A/ARF pathway inactivation in bladder cancer.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

The p53 tumor-suppressor gene

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Defining molecular profiles of poor outcome in patients with invasive bladder cancer using oligonucleotide microarrays

2 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

p53 and RB: simple interesting correlates or tumor markers of critical predictive nature?

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Tissue microarray analysis of cytoskeletal actin-associated biomarkers gelsolin and E-cadherin in urothelial carcinoma

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Evaluation of the performance of a p53 sequencing microarray chip using 140 previously sequenced bladder tumor samples

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Enhancement of G2 checkpoint function by gelsolin transfection in human cancer cells.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2043525

Genetic alterations in bladder cancer

23 September 2018

1 reference

12 December 2020

p53 mutations in human bladder cancer: genotypic versus phenotypic patterns

1 reference

12 December 2020

Altered patterns of MDM2 and TP53 expression in human bladder cancer

1 reference

12 December 2020

Short-term culturing of low-grade superficial bladder transitional cell carcinomas leads to changes in the expression levels of several proteins involved in key cellular activities

1 reference

12 December 2020

Impact of alterations affecting the p53 pathway in bladder cancer on clinical outcome, assessed by conventional and array-based methods

1 reference

12 December 2020

Molecular profiling of bladder cancer using cDNA microarrays: defining histogenesis and biological phenotypes

1 reference

12 December 2020

10.2353/AJPATH.2007.070338

Identifiers

DOI

1 reference

12 August 2017

1 reference

12 August 2017

PubMed publication ID

17982131

1 reference